share_log

Pfizer | 4: Statement of changes in beneficial ownership of securities-Officer BOURLA ALBERT

SEC ·  May 16 23:56
Summary by Futu AI
Pfizer Inc. (PFE) Chairman & CEO Albert Bourla executed a transaction of non-derivative securities on May 15, 2024. The details of the transaction, including the number of shares involved and the transaction price, have not been disclosed. The action reflects a change in Bourla's holdings in the company, but the specific nature and impact on his total share ownership remain unspecified. Investors are advised to monitor official filings for complete transaction details.
Pfizer Inc. (PFE) Chairman & CEO Albert Bourla executed a transaction of non-derivative securities on May 15, 2024. The details of the transaction, including the number of shares involved and the transaction price, have not been disclosed. The action reflects a change in Bourla's holdings in the company, but the specific nature and impact on his total share ownership remain unspecified. Investors are advised to monitor official filings for complete transaction details.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.